University of Texas/Texas AM Investment Management Co (UTIMCO)’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.29M Sell
9,103
-6,154
-40% -$1.71M 0.27% 60
2026
Q1
$3.79M Buy
+15,257
New +$3.63M 0.55% 36
2025
Q1
Sell
-156
Closed -$32.3K 217
2024
Q4
$32.3K Hold
156
﹤0.01% 150
2024
Q3
$29.6K Sell
156
-3,737
-96% -$674K ﹤0.01% 138
2024
Q2
$692K Sell
3,893
-3,431
-47% -$611K 0.13% 76
2024
Q1
$1.39M Buy
7,324
+3,199
+78% +$629K 0.29% 56
2023
Q4
$850K Buy
4,125
+3,969
+2,544% +$826K 0.23% 43
2023
Q3
$31.6K Buy
+156
New +$32.4K 0.01% 70

Other funds holding VRSN

University of Texas/Texas AM Investment Management Co (UTIMCO)'s VRSN Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) reduced its VeriSign (VRSN) stake by 40% in Q2 2026, selling an estimated $1.71M and leaving 9,103 shares worth $2.29M. The position accounts for 0.27% of the portfolio, ranked #60.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in VRSN in Q3 2023 and has held it in 8 quarters since. The position peaked at $3.79M in Q1 2026. 590 funds tracked by Wall St. Rank hold VRSN as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 9,103 shares of VeriSign worth $2.29M as of Q2 2026.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 6,154 VeriSign shares in Q2 2026, an estimated $1.71M.
  • VeriSign made up 0.27% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #60 holding.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in VeriSign in Q3 2023 and has held it in 8 quarters since.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s VeriSign position peaked at $3.79M in Q1 2026.
  • 590 funds tracked by Wall St. Rank held VeriSign as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.